Lactose malabsorption is a risk factor for decreased bone mineral density in pancreatic insufficient cystic fibrosis patients

European Journal of Human Genetics

Volumn 20, Issue 10, 2012, Pages 1092-1095

  Ma̧dry, Edyta ^a   Krasińska, Beata ^a   Drzymaa Czyz, Sławomira ^a   Sands, Dorota ^b   Lisowska, Aleksandra ^a   Grebowiec, Philip ^a   Minarowska, Alina ^c   Oralewska, Beata ^d   Mańkowski, Przemyslaw ^a   Moczko, Jerzy ^a   Walkowiak, Jarosław ^a,e  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Department of Pediatrics Mother and Child Health Institute   (Poland)

^c Department of Human Anatomy Medical   (Poland)

^d CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^e POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

adult type hypolactasia; bone mineral density; cystic fibrosis; lactose malabsorption

Indexed keywords

COLECALCIFEROL;

ADULT; ARTICLE; BONE DENSITY; CALCIUM INTAKE; CHILD; CYSTIC FIBROSIS; FEMALE; GENOTYPE; HUMAN; HYDROGEN BREATH TEST; LACTASE DEFICIENCY; LACTOSE INTOLERANCE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MILK PRODUCTION; NUTRITIONAL STATUS; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BODY WEIGHT; BONE DEMINERALIZATION, PATHOLOGIC; BONE DENSITY; BREATH TESTS; CALCIUM; CHILD; CHOLECALCIFEROL; CYSTIC FIBROSIS; FEMALE; HUMANS; LACTASE; LACTOSE INTOLERANCE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 84866539278     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.52     Document Type: Article

References (34)

1. Aris RM, Merkel PA, Bachrach LK et al: Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Meta 2005; 90: 1888-1896. (Pubitemid 40464064)
2. Mischler EH, Chesney PJ, Chesney RW, Mazess RB: Demineralization in cystic fibrosis detected by direct photon absorptiometry. Am J Dis Child 1979; 133: 632-635. (Pubitemid 9212667)
3. Hahn TJ, Squires AE, Halstead LR, Strominger DB: Reduced serum 25-hydroxyvitamin D concentration and disordered mineral metabolism in patients with cystic fibrosis J Pediatr 1979; 94: 38-42. (Pubitemid 9036125)
4. Cystic Fibrosis Foundation. http://www.cff.org/aboutcf/faqs/#What-is-the- life-expectan-cy-for-people-who-have-CF-%28in-the-United-States%29?/(accessed 9 Nov 2011).
5. Gore AP, Kwon SH, Stenbit AE: A roadmap to the brittle bones of cystic fibrosis J Osteoporos, Article ID926045: 1-10. Published online 2011.
6. Ott SM, Aitken ML: Osteoporosis in patients with cystic fibrosis. Clin Chest Med 1998; 19: 555-567. (Pubitemid 28421628)
7. Conway SP, Morton AM, Oldroyd B et al: Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 2000; 55: 798-804. (Pubitemid 30660911)
8. Bhudhikanok GS, Wang MC, Marcus R, Harkins A, Moss R, Bachrach LK: Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study J Pediatr 1998; 133: 18-27. (Pubitemid 28323900)
9. Aris RM, Lester GE, Camaniti M et al: Efficacy of alendronate in adults with cystic fibrosis with low bone density. Am J Respir Crit Care Med 2004; 169: 77-82. (Pubitemid 38233892)
10. Aris RM, Stevens A, Ontjes DA et al: Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. Am J Respir Crit Care Med 2000; 162: 1674-1678.
11. Walkowiak J: Assessment of maldigestion in cystic fibrosis. J Pediatr 2004; 145: 285-287. (Pubitemid 39165669)
12. Walkowiak J, Nousia-Arvanitakis S, Henker J, Stern M, Sinaasappel M, Dodge JA: Indirect pancreatic function tests in children. J Pediatr Gastroenterol Nutr 2005; 40: 107-114. (Pubitemid 40269722)
13. Semenza G, Auricchio S, Mantei N: Small-intestinal disaccharidases; in Scriver CR (eds) The metabolic and molecular basis of inherited disease. New York: McGraw-Hill, 2001; 1623-1650.
14. Ingram CJ, Mulcare CA, Itan Y, Thomas MG, Swallow DM: Lactose digestion and the evolutionary genetics of lactase persistence. Hum Genet 2009; 124: 57991.
15. Heyman MB: Lactose intolerance in infants, children, and adolescents. Pediatrics 2006; 118: 127986.
16. Di Stefano M, Veneto G, Malservisi S et al: Lactose malabsorption and intolerance and peak bone mass. Gastroenterology 2002; 122: 1793-1799. (Pubitemid 34651423)
17. Enattah NS, Sahi T, Savilahti E et al: Identification of a variant associated with adult-type hypolactasia. Nat Genet 2002; 30: 233-237.
18. Madry E, Fidler E, Sobczyńska-Tomaszewska A et al: Mild CFTR mutations and genetic predisposition to lactase persistence in cystic fibrosis. Eur J Hum Genet 2011; 19: 748-752.
19. Madry E, Lisowska A, Kwiecień J et al: Adult-type hypolactasia and lactose malabsorption in Poland. Acta Biochim Pol 2010; 57: 585-588.
20. Walkowiak J, Przyslawski J: Five-year prospective analysis of dietary intake and clinical status in malnourished cystic fibrosis patients. J Hum Nutr Diet 2003; 16: 225-231. (Pubitemid 36939501)
21. Krawczynski M, Walkowiak J, Krzyzaniak A: Secular changes in body height and weight in children and adolescents in Poznan, Poland, between 1880 and 2000. Acta Paediatr 2003; 92: 277-282. (Pubitemid 36408080)
22. Grey AB, Ames RW, Matthews RD, Reid IR: Bone mineral density and body composition in adult patients with cystic fibrosis. Thorax 1993; 48: 589-593. (Pubitemid 23188429)
23. Tschopp O, Boehler A, Speich R et al: Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease Am J Transplant 2002; 2: 167-172. (Pubitemid 36306796)
24. Schulman RC, Weiss AJ, Mechanick JI: Nutrition, bone, and aging: an integrative physiology approach. Curr Osteoporos Rep 2011; 9: 184-195.
25. King SJ, Topliss DJ, Kotsimbos T et al: Reduced bone density in cystic fibrosis: deltaf508 mutation is an independent risk factor. Eur Respir J 2005; 25: 54-61. (Pubitemid 40207731)
26. Aris RM, Lester GE, Caminiti M et al: Efficacy of alendronate in adults with cystic fibrosis with low bone density. Am J Respir Crit Care Med 2004; 169: 77-82. (Pubitemid 38233892)
27. Chapman I, Greville H, Ebeling PR et al: Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF). Clin Endocrinol 2009; 70: 838-846.
28. Bianchi ML, Romano G, Saraifoger S, Costantini D, Limonta C, Colombo C: BMD and body composition in children and young patients affected by cystic fibrosis J Bone Miner Res 2006; 21: 388-396.
29. Buntain HM, Greer RM, Schluter PJ et al: Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study Thorax 2004; 59: 149-155. (Pubitemid 38223487)
30. Sermet-Gaudelus I, Castanet M, Retsch-Bogart G, Aris R: Update on cystic fibrosis-related bone disease: a special focus on children. Paediatr Respir Rev 2009; 10: 134-142.
31. Schulze KJ, O'Brien KO, Germain-Lee EL, Booth SL, Leonard A, Rosenstein BJ: Calcium kinetics are altered in clinically stable girls with cystic fibrosis. J Clin Endocrinol Metab 2004; 89: 3385-3391. (Pubitemid 38951908)
32. Kolars JC, Levitt MD, Aouji M, Savaiano DA: Yogurt-an autodigesting source of lactose. N Engl J Med 1984; 310: 1-3.
33. Martini MC, Kukielka D, Savaiano DA: Lactose digestion from yogurt: influence of a meal and additional lactose. Am J Clin Nutr 1991; 53: 1253-1258.
34. Madry E, Krasińska B, Woźniewicz M et al: Tolerance of different dairy products in subjects with symptomatic lactose malabsorption due to adult type hypolactasia. Prz. Gastroenterol 2011; 5: 310-315.